These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles. Mitri N; Rahme K; Fracasso G; Ghanem E Nanotechnology; 2022 May; 33(31):. PubMed ID: 35417900 [TBL] [Abstract][Full Text] [Related]
23. Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? Craig GE; Brown SD; Lamprou DA; Graham D; Wheate NJ Inorg Chem; 2012 Mar; 51(6):3490-7. PubMed ID: 22390791 [TBL] [Abstract][Full Text] [Related]
24. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534 [TBL] [Abstract][Full Text] [Related]
25. Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers. Lin IC; Liang M; Liu TY; Ziora ZM; Monteiro MJ; Toth I Biomacromolecules; 2011 Apr; 12(4):1339-48. PubMed ID: 21384908 [TBL] [Abstract][Full Text] [Related]
26. Noncovalent intracellular drug delivery of hydrophobic drugs on Au NPs. Doane T; Burda C Methods Mol Biol; 2013; 1025():251-60. PubMed ID: 23918343 [TBL] [Abstract][Full Text] [Related]
27. Gold nanoparticles carrying diatomic molecules (O2 and CO) in aqueous solution. Karasugi K; Kitagishi H; Kano K Chem Asian J; 2011 Mar; 6(3):825-33. PubMed ID: 21265023 [TBL] [Abstract][Full Text] [Related]
28. Physical assessment of toxicology at nanoscale: nano dose-metrics and toxicity factor. Pompa PP; Vecchio G; Galeone A; Brunetti V; Maiorano G; Sabella S; Cingolani R Nanoscale; 2011 Jul; 3(7):2889-97. PubMed ID: 21547322 [TBL] [Abstract][Full Text] [Related]
29. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. Eck W; Craig G; Sigdel A; Ritter G; Old LJ; Tang L; Brennan MF; Allen PJ; Mason MD ACS Nano; 2008 Nov; 2(11):2263-72. PubMed ID: 19206392 [TBL] [Abstract][Full Text] [Related]
30. Dopamine Functionalized Polyethylene Glycol for Improving Stability of Gold Nanoparticles against Reactive Oxygen Species in Serum. Kang J; Wu FZ; Xue Y; Li ZH; Wang YX; Liu K Macromol Rapid Commun; 2022 Jul; 43(14):e2200035. PubMed ID: 35279895 [TBL] [Abstract][Full Text] [Related]
31. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles. Liu X; Huang N; Wang H; Li H; Jin Q; Ji J Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246 [TBL] [Abstract][Full Text] [Related]
32. Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. Llevot A; Astruc D Chem Soc Rev; 2012 Jan; 41(1):242-57. PubMed ID: 21785769 [TBL] [Abstract][Full Text] [Related]
33. Diminished spectrin extraction from ATP-depleted human erythrocytes. Evidence relating spectrin to changes in erythrocyte shape and deformability. Lux SE; John KM; Ukena TE J Clin Invest; 1978 Mar; 61(3):815-27. PubMed ID: 25286 [TBL] [Abstract][Full Text] [Related]
34. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Fytianos K; Rodriguez-Lorenzo L; Clift MJ; Blank F; Vanhecke D; von Garnier C; Petri-Fink A; Rothen-Rutishauser B Nanomedicine; 2015 Apr; 11(3):633-44. PubMed ID: 25555350 [TBL] [Abstract][Full Text] [Related]
35. Pegylated gold nanoparticles induce apoptosis in human chronic myeloid leukemia cells. Huang YC; Yang YC; Yang KC; Shieh HR; Wang TY; Hwu Y; Chen YJ Biomed Res Int; 2014; 2014():182353. PubMed ID: 24790990 [TBL] [Abstract][Full Text] [Related]
37. Synergetic approach for simple and rapid conjugation of gold nanoparticles with oligonucleotides. Li J; Zhu B; Yao X; Zhang Y; Zhu Z; Tu S; Jia S; Liu R; Kang H; Yang CJ ACS Appl Mater Interfaces; 2014 Oct; 6(19):16800-7. PubMed ID: 25188540 [TBL] [Abstract][Full Text] [Related]
38. Peptide functionalized gold nanoparticles: the influence of pH on binding efficiency. Harrison E; Hamilton JWJ; Macias-Montero M; Dixon D Nanotechnology; 2017 Jul; 28(29):295602. PubMed ID: 28632139 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells. Liu Z; Li W; Wang F; Sun C; Wang L; Wang J; Sun F Nanoscale; 2012 Nov; 4(22):7135-42. PubMed ID: 23070238 [TBL] [Abstract][Full Text] [Related]
40. Binding enhancement of antigen-functionalized PEGylated gold nanoparticles onto antibody-immobilized surface by increasing the functionalized antigen using alpha-sulfanyl-omega-amino-PEG. Yoshimoto K; Hoshino Y; Ishii T; Nagasaki Y Chem Commun (Camb); 2008 Nov; (42):5369-71. PubMed ID: 18985213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]